Balfour Beatty plc (BBY) is a leading engineering & construction business based in the UK. Balfour Beatty is listed on the London Stock Exchange (LSE) and employs 26,130 staff. All prices are listed in pence sterling.
|52-week range||162.2958p - 291.5384p|
|50-day moving average||274.9p|
|200-day moving average||248.1775p|
|Wall St. target price||338.33p|
|Dividend yield||0.06p (2.21%)|
|Earnings per share (TTM)||15.2p|
All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Valuing Balfour Beatty stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Balfour Beatty's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Balfour Beatty's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 18x. In other words, Balfour Beatty shares trade at around 18x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the FTSE 250 at the end of September 2019 (19.71). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Balfour Beatty's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 9.71. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Balfour Beatty's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Balfour Beatty's EBITDA (earnings before interest, taxes, depreciation and amortisation) is £72 million.
The EBITDA is a measure of a Balfour Beatty's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||£7.4 billion|
|Operating margin TTM||0.58%|
|Gross profit TTM||£382 million|
|Return on assets TTM||0.54%|
|Return on equity TTM||7.39%|
|Market capitalisation||£1.9 billion|
TTM: trailing 12 months
Dividend payout ratio: 13.82% of net profits
Recently Balfour Beatty has paid out, on average, around 13.82% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 2.21% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Balfour Beatty shareholders could enjoy a 2.21% return on their shares, in the form of dividend payments. In Balfour Beatty's case, that would currently equate to about 0.06p per share.
While Balfour Beatty's payout ratio might seem low, this can signify that Balfour Beatty is investing more in its future growth.
The latest dividend was paid out to all shareholders who bought their shares by 21 May 2020 (the "ex-dividend date").
Over the last 12 months, Balfour Beatty's shares have ranged in value from as little as 162.2958p up to 291.5384p. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (LSE average) beta is 1, while Balfour Beatty's is 0.8509. This would suggest that Balfour Beatty's shares are less volatile than average (for this exchange).
Balfour Beatty plc finances, designs, develops, builds, and maintains infrastructure in the United Kingdom, the United States, and internationally. It operates through Construction Services, Support Services, and Infrastructure Investments segments. The Construction Services segment provides civil engineering, building, ground engineering, mechanical and electrical, refurbishment, fit-out, and rail engineering services. The Support Services segment designs, upgrades, manages, and maintains water, gas, and electricity networks, as well as rail and highways. The Infrastructure Investments segment is involved in the acquisition, operation, and disposal of infrastructure assets, such as roads, hospitals, student accommodation, military housing, offshore transmission networks, waste and biomass, and other concessions. This segment also develops and finances public and private infrastructure projects. The company serves government departments and agencies, regulated utilities, and private sector organizations. Balfour Beatty plc was founded in 1909 and is based in London, the United Kingdom.
Learn more about Transportation and Logistics Systems’ recent performance and where you can invest in Transportation and Logistics Systems shares. We also run through some helpful rules of thumb for any investor.
Learn more about Charlie’s Holdings’ recent performance and where you can invest in Charlie’s Holdings shares. We also run through some helpful rules of thumb for any investor.
Learn more about Lemonade’s recent performance and where you can invest in Lemonade shares. We also run through some helpful rules of thumb for any investor.
Learn more about Unity Software’s recent performance and where you can invest in Unity Software shares. We also run through some helpful rules of thumb for any investor
Learn more about FuelCell Energy’s recent performance and where you can invest in FuelCell Energy shares. We also run through some helpful rules of thumb for any investor.
Learn more about CloudCommerce’s recent performance and where you can invest in CloudCommerce shares. We also run through some helpful rules of thumb for any investor
Ever wondered how to buy shares in Zomedica Pharmaceuticals? We explain how and compare a range of providers that can give you access to many brands, including Zomedica Pharmaceuticals.
Ever wondered how to buy shares in YRC Worldwide? We explain how and compare a range of providers that can give you access to many brands, including YRC Worldwide.
Ever wondered how to buy shares in Xeros Technology Group? We explain how and compare a range of providers that can give you access to many brands, including Xeros Technology Group.
Ever wondered how to buy shares in Xpediator? We explain how and compare a range of providers that can give you access to many brands, including Xpediator.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.